BioCryst Reports Agreement with PMDA on Phase 3 Clinical Trial and Regulatory Requirements for Marketing Authorization of BCX7353 in Japan Pharmaceutical Investing
Naturally Splendid Enterprises Ltd. Sub-Featured in the Cannabis Investor Magazine Cannabis Investing News
Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13 Medical Device Investing
EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel Pharmaceutical Investing
Harvest One Welcomes the Passage of Bill C-45 and the Announced Legalization Date of Cannabis in Canada Cannabis Investing News
Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients Biotech Investing
Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE Biotech Investing
Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor Biotech Investing
RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand Cannabis Investing News
ChroMedX Appoints Tom Glawdel as Chief Scientific Officer and HemoPalm Science Lead Medical Device Investing
